Mapping Pathways is a multi-national project to develop and nurture a research-driven, community-led global understanding of the emerging evidence base around the adoption of antiretroviral-based prevention strategies to end the HIV/AIDS epidemic. The evidence base is more than results from clinical trials - it must include stakeholder and community perspectives as well.

21 April 2011

Mapping Pathways at a Glance

What’s our mission?

Mapping Pathways aims to provide the research and analysis which communities and policymakers need in order to formulate coherent, evidence-based decisions for HIV/AIDS treatment and prevention strategies in the 21st century.

Who’s involved?

Mapping Pathways is a unique collaboration between six organizations:
  • The AIDS Foundation of Chicago
  • AIDS United
  • Baird’s CMC
  • The Desmond Tutu HIV Foundation
  • The Naz Foundation (India)
  • RAND Europe

How does this initiative work?

We will provide data and recommendations to policymakers, community leaders, and activists (and those who advise them) about the use of antiretroviral medicines to limit the number of new HIV infections by:
  • Finding out which information would be most helpful in making decisions about setting priorities and allocating health resources;
  • Conducting health economic analyses and secondary research to provide data;
  • Using sophisticated systems to establish an expert consensus on the relevance and reliability of the available analyses and information;
  • Providing its findings in forms that will be immediately useful, as well as choices and recommendations based on the findings.

Where are we focused, what’s our timeline, and who’s funding us?

Mapping Pathways is focused on the US, India, and South Africa. The findings could be adapted to other countries.

The program has already begun. Some preliminary findings and a progress report will be presented at regional AIDS meetings in Africa and North America in the fourth quarter of 2011. The work should be finished and ready to present at the 2012 International AIDS meeting in Washington DC.

Funding for the first year of Mapping Pathways is provided by Merck & Co. The project will need additional funding for its second phase.

[Content that is linked from other sources is for informational purposes and should not construe a Mapping Pathways position.]

No comments:

Post a Comment